• Use of antimicrobial medicines in animal agriculture exceeds human clinical use in many countries and there is evidence linking antimicrobial resistance (AMR) between people and animals.
• There is a need to understand attitudes, behaviours and motives among users including veterinarians and livestock producers.
• A review of the existing literature addressing AMR in agriculture reveals a lack of consensus around anti microbial use and its consequences.
• Effective policies to regulate antimicrobial use will require a better understanding of behavioural responses among users.
Antimicrobial resistance in animal agriculture: understanding user attitudes and behaviours
Dominic Moran
Antimicrobial use in animal production in some countries now exceeds use in human medicine. Animal uses in many countries are predominantly for growth promotion, or as a low cost substitute for other hygiene measures that could otherwise prevent infection in livestock.
The scientific consensus is that we need to reduce antimicrobial use, and to do this we need to understand more about user and prescriber practices, attitudes and beliefs, and the contexts within which they operate. In agriculture this includes veterinary practices and the nature of advice they provide to users, and what the latter know and believe about the problem. This is essentially the focus of the paper by Hockenhull and others, 2 summarised on p 510 of this week's Vet Record, who seek to derive largely qualitative insights from a review of relevant literature on animal antimicrobial use in the form of a rapid evidence assessment (REA).
The REA methodology is a systematic literature review that identifies a short list of peerreviewed research papers, in this case containing information on antimicrobial use in different livestock groups (including antimicrobial category and dosage), before setting out sections on attitudes and drivers of use among farmers and vets. The authors helpfully summarise the key drivers for reducing use, and some barriers to sustainable practice. Noteworthy observations include the broader role of knowledge exchange and the issue of justifying antimicrobial use on animal welfare grounds.
The summary provides some intriguing pointers for further research, although in some cases there are evident trade-offs and contradictions that warrant further exploration. For example, a statement that high (farm) production costs reduce capacity for reducing antimicrobial use, would seem counterintuitive.
Recent evidence collected from pig farms in Europe indicates that farmers and their advisors are using antimicrobials in an inefficient manner at farm-level regardless of their implications for ANTIMICROBIAL resistance (AMR) is the quintessential planetary One Health challenge, with the problem of injudicious use of antimicrobial medicines in both clinical and veterinary practice attracting increasing regulatory scrutiny. 1 As with climate change we may already be exceeding planetary limits in the case of AMR. If we assume that there is a finite amount of resistance to infection in nature, then we are rapidly depleting it through drug misuse. In response we need to manage it carefully for current and future generations before it is irreversibly lost.
The real or sometimes illusory gains from antimicrobial use are perceived as private while the losses are social. Many antimicrobial users are either unaware or apparently discount wider social and long-term consequences of private use, partly because these consequences are hard to observe. This scenario defines some of the key issues for social scientists interested in changing behaviour towards antimicrobials. It also encapsulates many of the policy challenges, including the need to address information sharing between government and users, and the development of effective regulations when the impacts are felt differently across different countries, but are also transboundary.
to prove that they are efficient (ie, least cost). Addressing effectiveness is clearly crucial and with current scientific evidence we are simply unable to make clear recommendations on what interventions will work best. This is partly due to a lack of both cross-section and longitudinal evaluation of how behaviours can be changed and how this change manifests itself in longer term data on AMR status in the field. Seeking such evidence will be costly and requires an investment in interdisciplinary research capacity that is only just beginning in many countries including the UK. 6 In designing interdisciplinary approaches the need to understand alternative research methodologies and different ways of problem framing is clearly vital.
Overall it is wrong to assume that the social science element is in some sense secondary to the issues of modelling and prevalence. People are integral to the biological complexity of AMR and so some assumptions about their motives and behaviours will be central to any credible scenarios about how the problem might be managed. AMR, 3 and that there is a diminishing rate of return on (costly) input usage. This could be either due to poor technical understanding of the input and output relationship and/or poor pricing of the input. Ultimately it is important to note that 48 papers inevitably provide differing levels of detail and some messages will warrant further scrutiny and validation using more quantitative evidence. For example, the contention that in-water treatment is cheaper.
Hockenhull and others 2 offer a valuable contribution in terms of alerting practitioners to other branches of AMR research and hopefully kicks off wider interest in social science and the need to focus on the true costs and benefits of regulatory options, and on behavioural change as a complement to developing predictive microbiological and epidemiological models to understand prevalence. Such models should ultimately be designed to help evaluate alternative regulatory interventions that can be categorised in terms of sermons, carrots and sticks.
A sermon approach is essentially improved knowledge exchange throughout the industry and between government agencies and other parts of the antimicrobial supply chain. The key research questions here are what messages are likely to work best in terms of changing or nudging behaviours and ultimately reducing AMR prevalence, and over what time period?
The carrot approach involves the use of more tangible incentives, such as farm payments or subsidies, to incentivise alternative biosecurity practices to obviate antimircrobial use. In this context, important questions involve the likely uptake of any incentive by the most profligate antimicrobial users, and whether we can effectively monitor and evaluate compliance with these restrictions.
The stick approach involves the use of more punitive fines or performance bonds, or more sophisticated market-based approaches to regulate use. This includes possible user charges (or taxes) as advocated by Van Boeckel, 4 effectively increasing the cost of using antimicrobials. Such charges would generate revenues that could be redirected for other specific purposes. An alternative approach might be the use of tradable permits that could manage antimicrobials by quantity, while offering a dynamic incentive to permit holders. 5 All these regulatory options need to be evaluated in terms of their technical effectiveness and
